DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Private Equity
Houston, TX
Since 2003, CRG has supported global healthcare industry innovation through healthcare growth capital financing and targeted healthcare investments.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | ADV type | Form D sold | GAV | LPs |
|---|---|---|---|---|---|---|
| CRG Partners V Cayman Parallel Fund LP | 2023 | Unknown | Private Equity Fund | n/a | $14.3M | 0 |
| CRG Partners V Delaware Parallel Fund LP | 2023 | Unknown | Private Equity Fund | n/a | $27.8M | 0 |
| CRG Partners V Cayman Parallel Fund "c" LP | 2023 | Unknown | Private Equity Fund | n/a | $77.8M | 0 |
| CRG Partners IV - Parallel Fund "c" (cayman) L.P. | 2019 | Active deployment | Private Equity Fund | n/a | $495M | 0 |
| CRG Partners IV L.P. | 2019 | Active deployment | Private Equity Fund | n/a | $248M | 0 |
| CRG Partners IV - Cayman Levered L.P. | 2019 | Active deployment | Private Equity Fund | n/a | $247M | 0 |
| CRG Partners III - Parallel Fund "a" L.P. | 2016 | Mature | Private Equity Fund | n/a | $42.5M | 0 |
| CRG Partners III L.P. | 2016 | Harvest | Private Equity Fund | n/a | $66.9M | 0 |
| CRG Partners III - Parallel Fund "b" (cayman) L.P. | 2016 | Harvest | Private Equity Fund | n/a | $168M | 0 |
| CRG Partners III (cayman) L.P. | 2016 | Harvest | Private Equity Fund | n/a | $158M | 0 |
| Parallel Investment Opportunities Partners II L.P. | 2013 | Harvest | Private Equity Fund | n/a | $7.1M | 0 |
| Capital Royalty Partners II - Parallel Fund "b" (cayman) L.P. | 2013 | Harvest | Private Equity Fund | n/a | $5.8M | 0 |
| Capital Royalty Partners II (cayman) L.P. | n/a | Harvest | Private Equity Fund | n/a | $25,337 | 0 |
| Capital Royalty Partners, L.P. | n/a | Wound down | Private Equity Fund | n/a | $88.9M | 0 |
| Loan Star Credit Opportunities Master Fund I | n/a | Wound down | Private Equity Fund | n/a | $43.2M | 0 |
| Capital Royalty Partners II - Parallel Fund "a" L.P. | n/a | Harvest | Private Equity Fund | n/a | $3.3M | 0 |
| Capital Royalty Partners (cayman), L.P. | n/a | Wound down | Private Equity Fund | n/a | $12.4M | 0 |
| Capital Royalty Partners II L.P. | n/a | Harvest | Private Equity Fund | n/a | $1.9M | 0 |
| Capital Royalty Parallel I, L.P. | n/a | Wound down | Private Equity Fund | n/a | $64.7M | 0 |
| Company | State | Role | Control | Invested | Exited | Status |
|---|---|---|---|---|---|---|
| Healthcare Services & IT | n/a | unknown | unknown | n/a | n/a | active |
Also named here, with no published line of their own (reach them through the firm): JP Giroux (Vice President), Kyle Simmons (Senior Accountant), Brian Englander (Principal), Carolyn Cranor (Executive Assistant to Charles Tate), Mark McClellan (MD, PhD), David R Carter (Partner), Sean Scanlan (Principal), Meredith Gamble (Principal), Phil Houston (Operating Partner), Nate Hukill (Managing Partner), CRG Logo (Chief Investment Officer), Colin Eckersley (Chief Financial Officer).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan